Bezár
Oktatás és kutatás  --  Publikációink

Oktatás és kutatás

Publikációink

Publikációink

2024. szeptember 18.
8 perc
1
Az SZTE SZAKK Gasztroenterológiai Centrumának nemzeti együttműködései:

2

Kiemelt közleményeink (2018-2024)

**listaszerűen, rákattintva az adott linkre vezet**

 

  1. Resál T, Bacsur P, Keresztes C, Bálint A, Bor R, Fábián A, Farkas B, Katsanos K, Michalopoylos G, Ribaldone DG, Attauabi M, Zhao M, Barak HA, Yanai H, Bezzio C, Rispo A, Castiglione F, Bar-Gil Shitrit A, Pugliese D, Armuzzi A, Savarino EV, Kolar M, Lukáš M, Chashkova E, Filip R, Rozieres A, Nancey S, Krznarić Ž, Schäfer E, Szamosi T, Sarlós P, Franko M, Drobne D, Knyazev OV, Kagramanova AV, Limdi J, Wetwittayakhlang P, Lakatos PL, Maharshak N, Bannon L, Nyári T, Szepes Z, Farkas K; TFB Study Group; Molnár T. Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study. Inflamm Bowel Dis. 2024 May 2;30(5):768-779.

link: https://academic.oup.com/ibdjournal/article/30/5/768/7237867

  1. Boldizsár Jójárt, Tamás Resál, Diána Kata, Tünde Molnár, Péter Bacsur, Viktória Szabó, Árpád Varga, Kata Judit Szántó, Petra Pallagi, Imre Földesi, Tamás Molnár, József Maléth, Klaudia Farkas, Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases, Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 392–405

link: https://academic.oup.com/ecco-jcc/article/18/3/392/7282409

  1. Farkas B, Ivány E, Bálint A, Bacsur P, Molnár T, Farkas K. Diagnostic and Therapeutic Challenges in Severe Peristomal Pyoderma Gangrenosum. Inflamm Bowel Dis. 2024 Jul 19:izae167. doi: 10.1093/ibd/izae167.

link: https://academic.oup.com/ibdjournal/article-lookup/doi/10.1093/ibd/izae167

  1. Bálint A, Farkas K, Méhi O, Kintses B, Vásárhelyi BM, Ari E, Pál C, Madácsy T, Maléth J, Szántó KJ, Nagy I, Rutka M, Bacsur P, Szűcs D, Szepes Z, Nagy F, Fábián A, Bor R, Milassin Á, Molnár T. Functional Anatomical Changes in Ulcerative Colitis Patients Determine Their Gut Microbiota Composition and Consequently the Possible Treatment Outcome. Pharmaceuticals (Basel). 2020 Oct 28;13(11):346.

link: https://www.mdpi.com/1424-8247/13/11/346

  1. Laszlo J. Barkai, Lorant Gonczi, Fruzsina Balogh, Dorottya Angyal, Klaudia Farkas, Bernadett Farkas, Tamas Molnar, Tamas Szamosi, Eszter Schafer, Petra A. Golovics, Mark Juhasz, Arpad Patai, Aron Vincze, Patricia Sarlos, Alexandra Farkas, Zsolt Dubravcsik, Tamas G. Toth, Hajnal Szekely, Pal Miheller, Peter L. Lakatos & Akos Ilias Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn’s disease patients over three years. Sci Rep 14, 14909 (2024).

link: https://www.nature.com/articles/s41598-024-65987-1#citeas

  1. Bálint, A., Rutka, M., Kolar, M., Bortlik, M., Duricova, D., Hruba, V., … Farkas, K. (2018). Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis – results from multicenter observational cohort. Expert Opinion on Biological Therapy, 18(11), 1181–1187.

link: https://www.tandfonline.com/doi/abs/10.1080/14712598.2018.1530758

  1. Judit Szántó K, Madácsy T, Kata D, Ferenci T, Rutka M, Bálint A, Bor R, Fábián A, Milassin Á, Jójárt B, Szepes Z, Nagy F, Molnár T, Földesi I, Maléth J, Farkas K. Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists. Expert Opin Biol Ther. 2021 Apr;21(4):539-548.

link: https://pubmed.ncbi.nlm.nih.gov/33583295/

  1. Bacsur P, Wetwittayakhlang P, Resál T, Földi E, Vasas B, Farkas B, Rutka M, Bessissow T, Afif W, Bálint A, Fábián A, Bor R, Szepes Z, Farkas K, Lakatos PL, Molnár T. Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system. Therapeutic Advances in Gastroenterology. 2024;17.
  2. Fábián A, Bor R, Vasas B, Szűcs M, Tóth T, Bősze Z, Szántó KJ, Bacsur P, Bálint A, Farkas B, Farkas K, Milassin Á, Rutka M, Resál T, Molnár T, Szepes Z. Long-term outcomes after endoscopic removal of malignant colorectal polyps: Results from a 10-year cohort. World J Gastrointest Endosc. 2024 Apr 16;16(4):193-205.

link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11045354/

  1. Fábián A, Bor R, Gede N, Bacsur P, Pécsi D, Hegyi P, Tóth B, Szakács Z, Vincze Á, Ruzsics I, Rakonczay Z Jr, Erőss B, Sepp R, Szepes Z. Double Stenting for Malignant Biliary and Duodenal Obstruction: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol. 2020 Apr;11(4):e00161.

link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263659/

  1. Bor R, Vasas B, Fábián A, Szűcs M, Bősze Z, Bálint A, Rutka M, Farkas K, Tóth T, Resál T, et al. Risk Factors and Interpretation of Inconclusive Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology in the Diagnosis of Solid Pancreatic Lesions. Diagnostics. 2023; 13(17):2841.

link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486755/

  1. Bor R, Fábián A, Szűcs M, Bálint A, Rutka M, Tóth T, Czakó L, Farkas K, Buzás N, Milassin Á, Molnár T, Szepes Z. Comparison of therapeutic efficacy and treatment costs of self-expandable metal stents and plastic stents for management of malignant biliary obstruction. BMC Gastroenterol. 2023 Feb 16;23(1):41.

link: https://pubmed.ncbi.nlm.nih.gov/36797676/

  1. Despotov K, Klivényi P, Nagy I, Pálvölgyi A, Vécsei L, Rajda C. Rare co-occurrence of multiple sclerosis and Wilson's disease - case report. BMC Neurol. 2022 May 16;22(1):178.

link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109366/

  1. Zsóri, G., Czepán, M., Illés, D., Pálvölgyi, A., Nagy, I., & Czakó, L. (2017). Pancreatic Diabetes Mellitus and Heavy Drinking are Risk Factors for the Development of Liver Fibrosis in Alcoholic Chronic Pancreatitis. Pancreatic disorders & therapy, 7, 1-4.

link: https://www.semanticscholar.org/paper/Pancreatic-Diabetes-Mellitus-and-Heavy-Drinking-are-Zsóri-Czepán/b5ac35a030feddedbefc25714dbba7397b212037

  1. Illés D, Ivány E, Holzinger G, Kosár K, Volosinovszki H, Adam MG, Kamlage B, Zsóri G, Tajti M, Svébis M, Horváth V, Oláh I, Márta M, Váncsa Sz, Zádori N, Szentesi A, Czakó B, Hegyi P, Czakó L. New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES trial): Protocol of a Prospective, Multicentre Observational trial. BMJ Open. 2020;10:e037267.

link: https://bmjopen.bmj.com/content/10/11/e037267

  1. Pouw RE, Barret M, Biermann K, Bisschops R, Czakó L, et al. Endoscopic Tissue Sampling - Part 1: Upper Gastrointestinal and Hepato-pancreato-biliary tract. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2021;53(11):1174-1188.

link: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1611-5091

  1. Tóth I, Ábrahám S, Karamya Z, Benkő R, Matuz M, Nagy A, Váczi D, Négyessy A, Czakó B, Illés D, Tajti M, Ivány E, Lázár G, Czakó L. Multidisciplinary management of acute cholecystitis during the COVID-19 pandemic – experiences of a tertiary centre. Scientific Reports 2023;13:16257.

link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533883/

  1. Badaoui A, Teles de Campos S, Fusaroli P, Gincul R, Kahaleh M, Poley JW, Sosa Valencia L, Czakó L, Gines A, Hucl T, Kalaitzakis E, Petrone MC, Sadik R, van Driel L, Vandeputte L, Tham T. Curriculum for diagnostic endoscopic ultrasound training in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2024;56(3):222-240.

link: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2224-8704

  1. Tajti M, Pécsi D, Mátrai P, Gódi Sz, Hegyi P, Szentesi A, Altorjay I, Bakucz T, Orbán-Szilágyi Á, Szepes Z, Patai Á, Gyökeres T, Fejes R, Dubravcsik Zs, Vincze Á, Czakó L. Weekend ERCP has similar outcomes as weekday procedures – a propensity score match analysis from the Hungarian ERCP Registry. Therapeutic Advances in Gastroenterology 2024 (in press)

link: *** még nem elérhető a link****

  1. Balázs Csaba Németh, Anna Orekhova, Wenying Zhang, Shannon A Nortman, Tyler Thompson, Péter Hegyi, Maisam Abu-El-Haija. Novel p.K374E variant of CPA1 causes misfolding-induced hereditary pancreatitis with autosomal dominant inheritance. Gut. 2020 Apr;69(4):790-792.

link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596457/

  1. Andrea Geisz, Zsanett Jancsó, Balázs Csaba Németh, Eszter Hegyi, Miklós Sahin-Tóth. Natural single-nucleotide deletion in chymotrypsinogen C gene increases severity of secretagogue-induced pancreatitis in C57BL/6 mice. JCI Insight. 2019 Jun 18;4(14):e129717.

link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675558/

  1. Balázs Csaba Németh, Alexandra Demcsák, Andrea Geisz, Miklós Sahin-Tóth. Misfolding-induced chronic pancreatitis in CPA1 N256K mutant mice is unaffected by global deletion of Ddit3/Chop. Sci Rep. 2022 Apr 15;12(1):6357.

link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012826/

  1. Zsófia Gabriella Pesei, Zsanett Jancsó, Alexandra Demcsák, Balázs Csaba Németh, Sandor Vajda, Miklós Sahin-Tóth. Preclinical testing of dabigatran in trypsin-dependent pancreatitis. JCI Insight. 2022 Nov 8;7(21):e161145.

link: https://pubmed.ncbi.nlm.nih.gov/36136430/

  1. Berke G, Beer S, Gede N, Takáts A, Szentesi A, Hegyi P, Rosendahl J, Sahin-Tóth M, Németh BC, Hegyi E. Risk of chronic pancreatitis in carriers of the c.180C>T (p.Gly60=) CTRC variant: case-control studies and meta-analysis. Pancreatology. 2023 Aug;23(5):481-490.

link: https://pubmed.ncbi.nlm.nih.gov/37321941/


Készítő